Skip to Content
Merck
  • Why is the reduction of NO in cytochrome c dependent nitric oxide reductase (cNOR) not electrogenic?

Why is the reduction of NO in cytochrome c dependent nitric oxide reductase (cNOR) not electrogenic?

Biochimica et biophysica acta (2013-04-27)
Margareta R A Blomberg, Per E M Siegbahn
ABSTRACT

The membrane-bound enzyme cNOR (cytochrome c dependent nitric oxide reductase) catalyzes the reduction of NO in a non-electrogenic process. This is in contrast to the reduction of O2 in cytochrome c oxidase (CcO), the other member of the heme-copper oxidase family, which stores energy by the generation of a membrane gradient. This difference between the two enzymes has not been understood, but it has been speculated to be of kinetic origin, since per electron the NO reduction is more exergonic than the O2 reduction, and the energy should thus be enough for an electrogenic process. However, it has not been clear how and why electrogenicity, which mainly affects the thermodynamics, would slow down the very exergonic NO reduction. Quantum chemical calculations are used to construct a free energy profile for the catalytic reduction of NO in the active site of cNOR. The energy profile shows that the reduction of the NO molecules by the enzyme and the formation of N2O are very exergonic steps, making the rereduction of the enzyme endergonic and rate-limiting for the entire catalytic cycle. Therefore the NO reduction cannot be electrogenic, i.e. cannot take electrons and protons from the opposite sides of the membrane, since it would increase the endergonicity of the rereduction when the gradient is present, thereby increasing the rate-limiting barrier, and the reaction would become too slow. It also means that proton pumping coupled to electron transfer is not possible in cNOR. In CcO the corresponding rereduction of the enzyme is very exergonic.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
ProteoMass Cytochrome c MALDI-MS Standard, vial of 10 nmol, (M+H+) 12,361.96 Da by calculation
Sigma-Aldrich
Cytochrome c from Saccharomyces cerevisiae, ≥85% based on Mol. Wt. 12,588 basis
Sigma-Aldrich
Cytochrome c from equine heart, BioUltra, ≥99% (SDS-PAGE), powder, suitable for mammalian cell culture
Sigma-Aldrich
Cytochrome c from bovine heart, ≥95% based on Mol. Wt. 12,327 basis, powder, suitable for mammalian cell culture
Sigma-Aldrich
Cytochrome c from equine heart, ≥95% based on Mol. Wt. 12,384 basis
Sigma-Aldrich
Cytochrome c from equine heart, ≥95% (SDS-PAGE)
Sigma-Aldrich
Cytochrome c from equine heart, BioReagent, suitable for GFC marker
Sigma-Aldrich
Cytochrome c from bovine heart, ≥95% based on Mol. Wt. 12,327 basis
Sigma-Aldrich
Cytochrome c from pigeon breast muscle, ≥95% based on Mol. Wt. 12,173 basis